Y Combinator-backed Verge Genomics is seeking a Director of Computational Biology and AI Scientists/Engineers to advance its drug discovery platform. The company, which graduated from Y Combinator's Summer 2015 batch, is building AI-powered tools to accelerate pharmaceutical research and development.

Verge's computational biology team focuses on leveraging machine learning to analyze complex biological data and identify potential drug targets. The Director role will lead efforts to integrate AI systems with genomic data analysis, while the Scientist/Engineer positions will work on developing and implementing these computational models.

The hiring push comes as AI continues to transform drug discovery, with companies racing to apply machine learning to reduce development timelines and costs. Verge's platform aims to predict therapeutic targets by analyzing genetic data patterns, potentially shortening the traditional multi-year drug development cycle.